The results support the potential of TPX2 in the treatment of castration-resistant tumors and highlight the induction of apoptosis due to AIM1 and TMED3 inhibition especially in the androgen independent cancer cells (Supporting Figure S4). The gene discussed is CRYBG1; the disease is cancer.